Tekin G, Deveci B, Deveci E
Acta Cir Bras. 2024; 39:e391224.
PMID: 38477786
PMC: 10926970.
DOI: 10.1590/acb391224.
Li L, Yu B, Lai Y, Shen S, Yan Y, Dong G
Front Pharmacol. 2024; 14:1279516.
PMID: 38375209
PMC: 10875678.
DOI: 10.3389/fphar.2023.1279516.
Nickle A, Ko S, Merrill A
Differentiation. 2023; 139:100733.
PMID: 37858405
PMC: 11009566.
DOI: 10.1016/j.diff.2023.10.001.
Tran D, Yoshioka N, Bizen N, Mori-Ochiai Y, Yano M, Yanai S
Dis Model Mech. 2023; 16(7).
PMID: 37415561
PMC: 10399444.
DOI: 10.1242/dmm.050169.
Huang Q, Liu B, Wu W
Oxid Med Cell Longev. 2023; 2023:8003821.
PMID: 37077657
PMC: 10110389.
DOI: 10.1155/2023/8003821.
The dark proteome: translation from noncanonical open reading frames.
Wright B, Yi Z, Weissman J, Chen J
Trends Cell Biol. 2021; 32(3):243-258.
PMID: 34844857
PMC: 8934435.
DOI: 10.1016/j.tcb.2021.10.010.
Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.
Koleini N, Nickel B, Nagalingam R, Landry N, Fandrich R, Cheung D
Cell Tissue Res. 2021; 385(3):753-768.
PMID: 34057573
DOI: 10.1007/s00441-021-03465-0.
What Can We Learn from FGF-2 Isoform-Specific Mouse Mutants? Differential Insights into FGF-2 Physiology In Vivo.
Freiin von Hovel F, Kefalakes E, Grothe C
Int J Mol Sci. 2021; 22(1).
PMID: 33396566
PMC: 7795026.
DOI: 10.3390/ijms22010390.
Non-AUG start codons: Expanding and regulating the small and alternative ORFeome.
Cao X, Slavoff S
Exp Cell Res. 2020; 391(1):111973.
PMID: 32209305
PMC: 7256928.
DOI: 10.1016/j.yexcr.2020.111973.
Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms.
Xiao L, Williams D, Hurley M
Endocrinology. 2020; 161(1).
PMID: 31901095
PMC: 6959088.
DOI: 10.1210/endocr/bqz016.
Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease.
Coffin J, Homer-Bouthiette C, Hurley M
J Endocr Soc. 2018; 2(7):657-671.
PMID: 29942929
PMC: 6009610.
DOI: 10.1210/js.2018-00105.
FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice.
Xiao L, Homer-Bouthiette C, Hurley M
J Bone Miner Res. 2018; 33(7):1347-1361.
PMID: 29502359
PMC: 11034775.
DOI: 10.1002/jbmr.3417.
Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L, Du E, Homer-Bouthiette C, Hurley M
Endocrinology. 2017; 158(10):3629-3646.
PMID: 28938491
PMC: 5659690.
DOI: 10.1210/en.2016-1617.
Angiogenic growth factors in myocardial infarction: a critical appraisal.
Thiagarajan H, Thiyagamoorthy U, Shanmugham I, Nandagopal G, Kaliyaperumal A
Heart Fail Rev. 2017; 22(6):665-683.
PMID: 28639006
DOI: 10.1007/s10741-017-9630-7.
High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal.
Kole D, Grella A, Dolivo D, Shumaker L, Hermans W, Dominko T
Stem Cell Res. 2017; 21:106-116.
PMID: 28433654
PMC: 5504699.
DOI: 10.1016/j.scr.2017.04.006.
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.
Akl M, Nagpal P, Ayoub N, Tai B, Prabhu S, Capac C
Oncotarget. 2016; 7(28):44735-44762.
PMID: 27007053
PMC: 5190132.
DOI: 10.18632/oncotarget.8203.
Age-Related Changes in FGF-2, Fibroblast Growth Factor Receptors and β-Catenin Expression in Human Mesenchyme-Derived Progenitor Cells.
Hurley M, Gronowicz G, Zhu L, Kuhn L, Rodner C, Xiao L
J Cell Biochem. 2015; 117(3):721-9.
PMID: 26332075
PMC: 4861164.
DOI: 10.1002/jcb.25357.
A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system.
Forthmann B, Grothe C, Claus P
Cell Mol Life Sci. 2015; 72(9):1651-62.
PMID: 25552245
PMC: 11113852.
DOI: 10.1007/s00018-014-1818-6.
Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma.
Lien I, Horng L, Hsu P, Wu C, Sung H, Wu R
Genes Cancer. 2014; 5(3-4):127-41.
PMID: 25053990
PMC: 4091528.
DOI: 10.18632/genesandcancer.11.
Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling.
Tassone E, Valacca C, Mignatti P
J Cell Physiol. 2014; 230(2):366-77.
PMID: 24986796
PMC: 4281515.
DOI: 10.1002/jcp.24717.